__timestamp | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 15879000000 | 2819557000 |
Thursday, January 1, 2015 | 16560000000 | 4103728000 |
Friday, January 1, 2016 | 19427000000 | 4860427000 |
Sunday, January 1, 2017 | 20776000000 | 5872227000 |
Monday, January 1, 2018 | 22561000000 | 6710800000 |
Tuesday, January 1, 2019 | 26145000000 | 7863400000 |
Wednesday, January 1, 2020 | 42518000000 | 8497100000 |
Friday, January 1, 2021 | 46385000000 | 16071700000 |
Saturday, January 1, 2022 | 46159000000 | 12172900000 |
Sunday, January 1, 2023 | 45006000000 | 13117200000 |
Monday, January 1, 2024 | 48300000000 | 14202000000 |
Unveiling the hidden dimensions of data
In the competitive landscape of the pharmaceutical industry, Bristol-Myers Squibb Company and Regeneron Pharmaceuticals, Inc. have showcased remarkable revenue trajectories over the past decade. Since 2014, Bristol-Myers Squibb has seen its revenue more than double, peaking in 2021 with a staggering 192% increase from its 2014 figures. This growth is largely attributed to strategic acquisitions and a robust pipeline of innovative therapies.
On the other hand, Regeneron Pharmaceuticals has demonstrated a consistent upward trend, with its revenue growing by approximately 465% from 2014 to 2021. This impressive growth is driven by the success of its flagship products and a strong focus on research and development.
While both companies have experienced fluctuations, their ability to adapt and innovate in a rapidly changing market underscores their resilience and commitment to advancing healthcare solutions.
Novo Nordisk A/S vs Regeneron Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Johnson & Johnson or Regeneron Pharmaceuticals, Inc.?
Novartis AG or Bristol-Myers Squibb Company: Who Leads in Yearly Revenue?
Revenue Showdown: Bristol-Myers Squibb Company vs Alnylam Pharmaceuticals, Inc.
Bristol-Myers Squibb Company and Regeneron Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Corcept Therapeutics Incorporated
Bristol-Myers Squibb Company vs Ionis Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Veracyte, Inc.
Revenue Showdown: Bristol-Myers Squibb Company vs MorphoSys AG
Who Generates More Revenue? Bristol-Myers Squibb Company or Merus N.V.
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics